Emergent BioSolutions CEO Dumped $11M Of Stock Before Announcement About 15M Botched Doses Of Johnson & Johnson Vaccine Was Made Public
Emergent BioSciences' stock lost more than half of its value since the disclosure that it ruined as many as 15 million doses of Johnson & Johnson's Covid-19 vaccine at its Baltimore plant. But the company's CEO dumped more than $11 million worth of stock ahead of the stock's massive decline.